Fran Brown, PhD
Senior Vice President, Global Head, Drug Development Science从药物早期发现到报批和上市后，Fran 在全球战略性和运营性药物开发方面拥有超过 25 年的经验。她在战略性药物发现和开发方面拥有广泛的知识，尤其侧重于发展策略和模型引导的药物开发 (MIDD) 的应用。
Managing Director, Technomark Life Sciences
Allen Hakimi, Managing Director and CEO of Technomark. Mr. Hakimi joined Technomark Consulting Service Ltd. in the UK in 2006 and has successfully led its corporate transition to Technomark Life Sciences, which now invests via a co-development business model, by sharing the cost of pre-clinical development in exchange for downstream remuneration. Under this new co-funding model, Technomark has invested in 14 development programs, with successful exits of three programs through large pharma (Wyeth/Pfizer, BMS, D-Pharm Israel), and a fourth through IPO.
Senior Associate / EIR, Xontogeny
Jayanth is a Senior Associate at Xontogeny leveraging his diverse skill set to aid the due diligence efforts of the Xontogeny investment team.
Jayanth is experienced in building up multiple biotech and medtech ideas including cell therapies (cancer & autoimmune), engineered enzymes & antibodies, core needle biopsy devices, infectious disease diagnostics, and urinary microvalves. Over the course of advancing prior projects, Jay has been involved with TuckLab and Tuck-Magnuson Startup Incubator and is driven to aid in the advancement of biomedical innovations.
Jayanth received an AB degree in Economics from Dartmouth College, a BE degree in Biomedical Engineering and MEng degree in Biological/Chemical Engineering from Dartmouth’s Thayer School of Engineering. While at Dartmouth, Jay was an active member of the Dartmouth Entrepreneurial Network (DEN) Associates/Magnuson Center Student Leadership Board.
